SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs surges on plan to acquire Finoso Pharma for Rs 15 crore

15 Feb 2013 Evaluate

Vivimed Labs is currently trading at Rs. 325.85, up by 8.15 points or 2.57% from its previous closing of Rs. 317.70 on the BSE.

The scrip opened at Rs. 320.00 and has touched a high and low of Rs. 327.50 and Rs. 320.00 respectively. So far 13414 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 444.00 on 18-Apr-2012 and a 52 week low of Rs. 310.00 on 14-Feb-2013.

Last one week high and low of the scrip stood at Rs. 334.00 and Rs. 310.00 respectively. The current market cap of the company is Rs. 454.46 crore.

The promoters holding in the company stood at 45.15% while Institutions and Non-Institutions held 3.57% and 51.28% respectively. 

Vivimed Labs has proposed to acquire Finoso Pharma for a total consideration of Rs 15 crore comprising cash, stock and deferred payment. Post acquisition, Finoso will become Vivimed’s research and development (R&D) unit to support innovators, generics and licensing efforts.

Finoso Pharma is a pharmaceutical development services company focused on formulations product development efforts for multiple markets and develops globally accepted dossiers.

Vivimed Labs Share Price

7.26 -0.38 (-4.97%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×